Cargando…
Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates
BACKGROUND: Stomach adenocarcinoma (STAD) ranks as the third leading cause of cancer death worldwide. TGF‑β receptor 1 (TGFBR1), serving important roles in the TGF‑β family, the mechanisms whereby TGFBR1 governs tumor progression, immune cell infiltration in STAD remains unintelligible. METHODS: We...
Autores principales: | He, Yi, Zhang, Haiyang, Zhang, Yan, Wang, Peiyun, Zhu, Kegan, Ba, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965104/ https://www.ncbi.nlm.nih.gov/pubmed/35368798 http://dx.doi.org/10.2147/IJGM.S353879 |
Ejemplares similares
-
Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
por: Liu, Ye, et al.
Publicado: (2023) -
Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes
por: Chang, Jin-Jia, et al.
Publicado: (2022) -
Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023) -
An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022) -
CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma
por: Zhang, Jingxin, et al.
Publicado: (2022)